Share the post "Sarda Proteins announced Financial Results Q1 2024-25"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Profit over the Year and quarter: Significant improvement in profitability for Sarda Proteins Ltd. Notable increase of 2566.67 % in net profit Year to Year, Sarda Proteins Ltd’s profitability dropped by -500 % Quarter to Quarter.
- EPS over the Year and quarter: EPS increased by 4,500.00 % Year to Year. EPS decreased by -483.33 % in previous quarter. Analysis needed for shareholder value.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 0.236 Cr | Rs. 0.06 Cr | Rs. 0 Cr | 0 % | 0 % |
Expenses | Rs. 0.28 Cr | Rs. 0.08 Cr | Rs. 0.08 Cr | + 0 % | -71.43 % |
Operating Profit | Rs. -0.04 Cr | Rs. -0.02 Cr | Rs. -0.08 Cr | -300 % | -100 % |
OPM % | -16.95 % | -33.33 % | 0 % | + 33.33 % | + 16.95 % |
Other Income | Rs. 0.041 Cr | Rs. 0.041 Cr | Rs. 0 Cr | 0 % | 0 % |
Interest | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
Depreciation | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
Profit before tax | Rs. 0 Cr | Rs. 0.02 Cr | Rs. -0.08 Cr | -500 % | 0 % |
Tax % | -0 % | 5 % | -0 % | -5 % | 0 % |
Net Profit | Rs. -0 Cr | Rs. 0.02 Cr | Rs. -0.08 Cr | -500 % | 0 % |
EPS in Rs | Rs. -0.01 | Rs. 0.12 | Rs. -0.46 | -483.33 % | -4500 % |
Today, we’re looking at Sarda Proteins Ltd’s financial performance for the Q1(Jun 2024).Expenses ticked up slightly by 0 % quarter-on-quarter, aligning with the annual decline of -71.43 %. Operating profit, while down -100 % compared to last year, faced a quarter-on-quarter dip of -300 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 16.95 %, but an expansion of 33.33 % sequentially. but saw a reduction from the preceding quarter by -500 %.
with a more notable quarter-on-quarter decrease of -5 %. but witnessed a -500 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -4500 % but a quarterly fall of -483.33 %. In summary, Sarda Proteins Ltd’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 0.236 Cr | Rs. 0.06 Cr | Rs. 0 Cr | 0 % | 0 % |
Expenses | Rs. 0.28 Cr | Rs. 0.08 Cr | Rs. 0.08 Cr | + 0 % | -71.43 % |
Operating Profit | Rs. -0.04 Cr | Rs. -0.02 Cr | Rs. -0.08 Cr | -300 % | -100 % |
Net Profit | Rs. -0 Cr | Rs. 0.02 Cr | Rs. -0.08 Cr | -500 % | 0 % |
EPS in Rs | Rs. -0.01 | Rs. 0.12 | Rs. -0.46 | -483.33 % | -4500 % |
In reviewing Sarda Proteins Ltd’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Expenses decreased by -71.43 % compared to the previous year, with a 0 % increase quarter-on-quarter. Operating Profit dropped by -100 % annually, and saw a -300 % decrease from the last quarter.
and experienced a -500 % decrease from the previous quarter. Earnings Per Share (EPS) fell by -4500 % annually, however dipped by -483.33 % compared to the last quarter. In essence, while Sarda Proteins Ltd faces strong annual decline indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.